Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.090 | AlteredExpression | disease | BEFREE | WISP2 exhibits its potential antitumor activity via targeting ERK and E-cadherin pathways in esophageal cancer cells. | 30808397 | 2019 | ||||
|
0.090 | Biomarker | disease | BEFREE | Cordycepin Induces Apoptosis and G2/M Phase Arrest through the ERK Pathways in Esophageal Cancer Cells. | 31258746 | 2019 | ||||
|
0.090 | Biomarker | disease | BEFREE | Overexpression of macrophage stimulating 1 enhances the anti-tumor effects of IL-24 in esophageal cancer via inhibiting ERK-Mfn2 signaling-dependent mitophagy. | 30981108 | 2019 | ||||
|
0.090 | Biomarker | disease | BEFREE | In conclusion, the present results indicate that the antiproliferative effect of eupatilin on esophageal cancer TE1 cells is associated with inhibition of the Akt and ERK pathways. | 29693162 | 2018 | ||||
|
0.090 | AlteredExpression | disease | BEFREE | The interplay of dual MET/HER2 overexpression in the AKT and ERK pathways for esophageal cancer is described. | 29223420 | 2018 | ||||
|
0.090 | Biomarker | disease | BEFREE | CUL7 may promote EMT via the ERK‑SNAI2 pathway in EC. | 29393450 | 2018 | ||||
|
0.090 | Biomarker | disease | BEFREE | Our results indicate that RUNX2 may play an oncogenic role in esophageal carcinoma by activating the PI3K/ AKT and ERK pathways. | 30138923 | 2018 | ||||
|
0.090 | Biomarker | disease | BEFREE | These results indicated that miR-133a could inhibit the MEK/ERK pathway to promote cell apoptosis and enhance radio-sensitivity by targeting EGFR in EC.. | 27933650 | 2017 | ||||
|
0.090 | Biomarker | disease | BEFREE | Our findings depict the presence of activated ERK despite the low frequency of upstream alterations, implicating ERK activation in the acquisition of a more aggressive phenotype in esophageal cancer. | 22658382 | 2012 |